Elevate your local knowledge

Sign up for the iNFOnews newsletter today!

Select Region

Selecting your primary region ensures you get the stories that matter to you first.

Sixth complainant to continue testifying at Frank Stronach’s sexual assault trial

Sixth complainant to continue testifying at Frank Stronach's sexual assault trial | iNFOnews.ca
Frank Stronach arrives at a Toronto Court on Tuesday February 3, 2026. THE CANADIAN PRESS/Chris Young

TORONTO — One of the complainants in Frank Stronach’s sexual assault trial is set to continue testifying today after an emotional first day on the stand.

The woman is the sixth of seven complainants expected to testify in the trial, which began early this month after some delay.

Her testimony Wednesday was interspersed with tears and pauses to calm herself down.

The woman told the court she became a “social recluse” after Stronach sexually assaulted her in 1986.

Stronach, who became one of Canada’s wealthiest people after founding the auto parts manufacturer Magna International, has pleaded not guilty to 12 charges stemming from alleged incidents dating as far back as the 1970s.

On Wednesday, prosecutors withdrew one count of forcible confinement related to the complainant on the stand.

This report by The Canadian Press was first published Feb. 26, 2026.

News from © The Canadian Press, . All rights reserved.
This material may not be published, broadcast, rewritten or redistributed.

Join the Conversation!

Want to share your thoughts, add context, or connect with others in your community?

Create a free account

The Canadian Press

The Canadian Press is Canada's trusted news source and leader in providing real-time, bilingual multimedia stories across print, broadcast and digital platforms.

Related Articles

B.C. man cured of rare disease in world-first for new gene-editing technology | iNFOnews.ca
Ty Sperle is shown in this undated handout photo after receiving treatment. Sperle, a 19-year-old resident of Kelowna, B.C., has been cured of a rare disease called chronic granulomatous disease in the first use of a genetic technology known as "prime editing" as part of a clinical trial by U.S.-based Prime Medicine. THE CANADIAN PRESS/Handout - Sperle family (Mandatory Credit)

B.C. man cured of rare disease in world-first for new gene-editing technology